These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 6086864)

  • 1. New cephalosporins: in-vitro activity against gram-negative bacilli and suggestions for possible clinical use.
    Bakken JS; Hulsund M
    J Oslo City Hosp; 1984 May; 34(5):41-7. PubMed ID: 6086864
    [No Abstract]   [Full Text] [Related]  

  • 2. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
    Rouhan D; Le Noc P; Le Noc D
    Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the in-vitro activity of cefepime and other cephalosporins.
    Lim VK; Halijah MY
    Malays J Pathol; 1993 Jun; 15(1):65-8. PubMed ID: 8277793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
    Duval J; Soussy CJ; Deforges L; Le Van Thoi J; Acar JF; Kitzis D; Dabernat H; Christol D; Bure A; Courtieu AL
    Pathol Biol (Paris); 1983 May; 31(5):357-61. PubMed ID: 6312397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of gentamicin-resistant gram-negative bacilli to tobramycin, netilmicin and amikacin as well as synergism with cephalosporins.
    Kedzia WB; Mirska I
    J Chemother; 1989 Jul; 1(4 Suppl):367-8. PubMed ID: 16312443
    [No Abstract]   [Full Text] [Related]  

  • 9. Activity of cefepime (BMY-28142) and cefpirome (HR 810) against gram-negative bacilli resistant to cefotaxime or ceftazidime.
    Jones RN; Fuchs PC
    J Antimicrob Chemother; 1989 Jan; 23(1):163-5. PubMed ID: 2663806
    [No Abstract]   [Full Text] [Related]  

  • 10. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA; Day GJ; Humble MW
    N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative activity of ceftazidime and four other cephalosporins against gram-negative bacteria and their sensitivity to beta-lactamases.
    Galante D; Esposito S; Barba D; Pennucci C; Limauro D; Scioli C
    Chemioterapia; 1984 Aug; 3(4):250-4. PubMed ID: 6398123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of temocillin, moxalactam and cefotaxime against gram negative bacteria sensitive or resistant to ureidopenicillins and/or cefacedone.
    Bartmann K; Tarbuc R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Dec; 256(2):202-10. PubMed ID: 6324518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["In vitro" sensitivity of gram-negative bacteria in comparisons of moxalactam, cephaloridine, cefotaxime, piperacillin and tobramycin].
    Giola L; Rizzu D
    G Batteriol Virol Immunol; 1983; 76(7-12):207-13. PubMed ID: 6099295
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT; Andriole VT
    Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of automatic antimicrobial susceptibility testing with the MS-2 system.
    Mascellino MT; Prignano G; Lorenzi A; Iegri F; Catania S; Lancia O; Sorice F
    Boll Ist Sieroter Milan; 1984 May; 63(2):104-10. PubMed ID: 6466451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
    Baumgärtner M; Dickgiesser N; Müller S; Wundt W
    Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activities of third-generation cephalosporins.
    Fass RJ
    Arch Intern Med; 1983 Sep; 143(9):1743-5. PubMed ID: 6615095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compared sensitivities of 532 bacterial strains to six cephalosporins.
    Courtieu AL; Drugeon H
    Int J Clin Pharmacol Res; 1983; 3(3):195-201. PubMed ID: 6679522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents.
    Bell JM; Turnidge JD;
    Pathology; 2001 Feb; 33(1):53-60. PubMed ID: 11280610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
    Bujdáková H; Kallová J; Lausová A; Kettner M
    Microbios; 1995; 84(339):87-90. PubMed ID: 8628124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.